Sintasi degli acidi grassi
La sintasi degli acidi grassi (FAS) è un complesso multi-enzimatico responsabile della sintesi degli acidi grassi a catena lunga. La sovraespressione di FAS è associata a vari disturbi metabolici, tra cui obesità, diabete e cancro. L'inibizione di FAS può ridurre la biosintesi lipidica e indurre apoptosi nelle cellule tumorali, rendendola un obiettivo promettente per la terapia del cancro e la ricerca sulle malattie metaboliche. Presso CymitQuimica, offriamo una varietà di inibitori di FAS per supportare la tua ricerca in oncologia, metabolismo e sviluppo terapeutico.
Trovati 40 prodotti per "Sintasi degli acidi grassi".
Filtra per
Percentuale di purezza
0
100
|
0
|
50
|
90
|
95
|
100
- Prezzo più basso
- Prezzo più alto
- Purezza più bassa
- Purezza più alta
- Consegna più veloce
Fatostatin hydrobromide
CAS:Fatostatin hydrobromide (Fatostatin A HBr), an inhibitor of sterol regulatory element binding protein (SREBP), impairs the activation of SREBP-1 and SREBP-2.Formula:C18H19BrN2SPurezza:98.62% - 99.91%Colore e forma:SolidPeso molecolare:375.326Ref: TM-T6832
5mg48,00€1mL*10mM (DMSO)50,00€10mg70,00€25mg112,00€50mg182,00€100mg309,00€200mg447,00€500mg747,00€TVB-3664
CAS:TVB-3664 is an orally active, selective, highly bioavailable fatty acid synthase inhibitor (FASN).Cost-effective and quality-assured.Formula:C25H23F3N4O2Purezza:99.17% - 99.64%Colore e forma:SolidPeso molecolare:468.47Ref: TM-T17181
1mg114,00€5mg268,00€1mL*10mM (DMSO)268,00€10mg432,00€25mg708,00€50mg1.044,00€100mg1.423,00€Fas C-Terminal Tripeptide Acetate
Fas C-Terminal Tripeptide Acetate shows inhibitory activity of Fas/FAP-1 binding.Formula:C18H33N3O8Purezza:97.85%Colore e forma:White SolidPeso molecolare:419.47FGH10019
CAS:FGH10019 is a novel inhibitor of sterol regulatory element-binding protein (SREBP) ( IC50 :1 μM).Formula:C18H19N3O2S2Purezza:98.93%Colore e forma:SolidPeso molecolare:373.49Ref: TM-T7798
1mg70,00€5mg152,00€1mL*10mM (DMSO)156,00€10mg212,00€25mg355,00€50mg505,00€100mg685,00€200mg888,00€Ac-CoA Synthase Inhibitor1
CAS:Ac-CoA Synthase Inhibitor1 (ACSS2 inhibitor) is the most potent and specific inhibitor of acetate-dependent acetyl-CoA synthetase 2 (ACSS2).Formula:C20H18N4O2S2Purezza:99.26% - 99.84%Colore e forma:SolidPeso molecolare:410.51Fatostatin
CAS:Fatostatin inhibits SREBP-1/2 by binding to SCAP, blocking their ER-Golgi transport.Formula:C18H18N2SPurezza:99.77% - 99.92%Colore e forma:White SolidPeso molecolare:294.414Ref: TM-T9266
2mg34,00€5mg48,00€1mL*10mM (DMSO)50,00€10mg70,00€25mg112,00€50mg182,00€100mg309,00€200mg465,00€Betulin ditosylate
CAS:Betulinditosylate is a derivative of Betulin, which functions as an SREBP inhibitor.Formula:C44H62O6S2Colore e forma:SolidPeso molecolare:751.09HS80
CAS:HS-80, a Fasnall enantiomer, selectively inhibits FASN, blocking lipid synthesis (IC50: 7.13 μM).Formula:C19H22N4SPurezza:98%Colore e forma:SolidPeso molecolare:338.47HS79
CAS:HS-79, a Fasnall enantiomer, selectively inhibits FASN with an IC50 of 1.57 μM, blocking tritiated acetate lipid incorporation.Formula:C19H22N4SPurezza:98%Colore e forma:SolidPeso molecolare:338.47FASN-IN-4
CAS:FAS-IN-1 is a potent inhibitor of Fatty acid synthase (FAS) wtih IC50 of 10 nM.Formula:C26H27N3O4SPurezza:98%Colore e forma:SolidPeso molecolare:477.58FASN-IN-5
CAS:FASN-IN-5 is a FASN inhibitor, useful for studying cancer and metabolic diseases.Formula:C29H26N4O2Purezza:99.88%Colore e forma:SolidPeso molecolare:462.54Malic enzyme inhibitor ME1
CAS:Malic enzyme inhibitor ME1 (ME1) is a specific inhibitor of Malic enzyme (IC50 = 0.15 μM). Malic enzyme inhibitor ME1 reduces cell viability/metabolic activity.Formula:C20H21N3O3Purezza:99.91%Colore e forma:SolidPeso molecolare:351.4Ref: TM-T11940
1mg70,00€1mL*10mM (DMSO)148,00€5mg178,00€10mg326,00€25mg555,00€50mg790,00€100mg1.063,00€500mg2.152,00€CTL-06
CTL-06, a Fatty Acid Synthase (FASN) inhibitor with an IC50 of 3 μM, induces apoptosis, while CTL-12 impedes cell cycle progression in the Sub-G1/S phase andFormula:C21H21ClN4O4Colore e forma:SolidPeso molecolare:428.87SREBP/SCAP-IN-2
CAS:SREBP/SCAP-IN-2 (compound 13) acts as a selective inhibitor of SREBP/SCAP [1].Formula:C27H37ClF2N4OColore e forma:SolidPeso molecolare:507.06FASN-IN-1
CAS:FASN-in-1 is an effective, specific inhibitor of fatty acid synthase (FASN), a compound specifically designed to target and inhibit the activity of the enzymeFormula:C18H25N3O3S2Purezza:99.92% - >99.99%Colore e forma:White SolidPeso molecolare:395.541,3-Dipalmitoyl-2-Docosahexaenoyl Glycerol
CAS:1,3-Dipalmitoyl-2-docosahexaenoyl glycerol, a triacylglycerol, features palmitic acid at the sn-1 and sn-3 positions and docosahexaenoic acid at the sn-2 position. Its dietary administration (30 g/kg) has been shown to decrease hepatic triglyceride and cholesterol levels in mice.Formula:C57H98O6Colore e forma:SolidPeso molecolare:879.38FAS-IN-1 Tosylate
FAS-IN-1 Tosylate is an effective fatty acid synthase inhibitor;Has an IC50 of 10 nM.Formula:C33H35N3O7S2Purezza:98%Colore e forma:SolidPeso molecolare:649.78SREBP/SCAP-IN-1
CAS:SREBP/SCAP-IN-1 (compound 10b) serves as a selective inhibitor of SREBP/SCAP [1].Formula:C28H40F2N4OColore e forma:SolidPeso molecolare:486.64ONL-1204
CAS:ONL-1204 is a small molecule, CD95 antigen inhibitor (Fas inhibitor) being developed by ONL Therapeutics for the treatment of retinal detachment.Formula:C71H100N18O16Colore e forma:SolidPeso molecolare:1461.66PFM046
CAS:PFM046 is an antagonist of the liver X receptor (LXR), effectively inhibiting the activation of LXRα and LXRβ, with IC50 values of 2.04 μM and 1.58 μM respectively. It reduces the expression of SCD1 and FASN while increasing ABCA1 expression, and demonstrates antitumor activity in mouse models.Formula:C29H42O2Colore e forma:SolidPeso molecolare:422.643
